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ABNORMAL TIBIOFEMORAL CONTACT MECHANICS IN SUBJECTS
WITH MEDIAL AND LATERAL COMPARTMENT ARTICULAR
CARTILAGE LESIONS
S.Y. Segev, D. Kumar, L. Nardo, V. Pedoia, T.M. Link, S. Majumdar,
R.B. Souza. Univ. of California San Francisco, San Francisco, CA, USA
Purpose: To evaluate the changes in cartilage-on-cartilage contact areas
and medial and lateral contact area centroid movement in the tibiofe-
moral joint during knee ﬂexion and extension using MRI in subjects
with and without tibiofemoral cartilage lesion.
Methods: Subjects from an observational study on knee Osteoarthritis
(OA), including both subjects with andwithout radiographic OA, (n¼ 94
Mean age ¼ 54.1±10.5 years; Mean BMI ¼: 24.4±3.4 kg/m2; Men:-
Women ¼ 35:59) underwent 2D fast-spin echo (FSE) MR imaging at 0
and 30 of knee ﬂexion under axial loading (25% bodyweight). For
subjects with radiographic OA, the more severe knee was enrolled. For
subjects without radiographic OA, the enrolled knee was randomly
selected. A ﬂuid sensitive-fat-saturated 3D fast spin-echo sequence
with variable ﬂip angle (CUBE) was acquired in order to grade cartilage
lesions using a semi-quantitative score. Subjects were then stratiﬁed
into those with and without cartilage lesions at the tibiofemoral joint.
Tibiofemoral contact area was deﬁned on FSE images as the area of
contact between the tibial and femoral articular cartilage, excluding
meniscus contact area and joint ﬂuid. This region of contact was semi-
automatically segmented separately in the medial and lateral kneecompartment using Bezier-splines created with in-house software
written in Matlab. Contact area centroid position was determined by
evaluation of the contact area on a deﬁned anatomic coordinate system
embedded within the tibia. Differences in medial and lateral contact
area at ﬂexed and extended conditions, and medial and lateral contact
area centroid translations were compared between subjects with and
without cartilage lesions using analysis of co-variance (ANCOVA),
adjusted for age, gender, knee alignment, and BMI.
Results: Subjects with medial compartment cartilage lesions (n¼28)
had greater contact area in the affected compartment during extension
(Figure 1, 361 vs. 270 mm2; p¼0.025), but not ﬂexion (Figure 1, 287 vs.
219mm2; p¼0.146) when compared to subjects without lesions (n¼66).
No differences in contact area in the lateral compartment were
observed between subjects with and without medial compartment
lesions. In contrast, subjects with lesions in the lateral compartment
(n¼18) were found to have greater contact area than subjects without
lesions (n¼76) in both extension (Figure 2, 366 vs. 271 mm2; p¼0.009)
and ﬂexion (Figure 2, 326 vs. 224 mm2; p¼0.002) as well as in the
contralateral compartment while in full extension (Figure 2, 374 vs. 279
mm2; p¼0.012). With regard to contact kinematics, subjects with
medial compartment lesions had greater anterior-posterior translation
of the medial contact centroid when moving from extension to ﬂexion
(Figure 3, Figure 4, p¼0.047). No differences in anterior-posterior
centroid translations were observed in either the medial or lateral
compartment of subjects with lateral compartment lesions.
Conclusions: Contact mechanics in subjects with cartilage lesions are
signiﬁcantly different compared to those without lesions. The higher
contact area in subjects with cartilage lesions is likely due to the
changes in the ability of the cartilage to adapt to loading, expanding the
contact surface as the cartilage adjacent to the lesion gives way to the
load. This phenomenon is coupled with abnormal contact kinematics in
persons with cartilage lesions. While the normal kinematics of knee
ﬂexion requires the femur to slide back on the tibial plateau, our data
suggests that the movement in the affected compartment is greater in
knees with medial compartment cartilage lesions. This ﬁnding could be
related to knee instability, an extremely common symptom in patients
with OA. Taken together, these differences may be responsible for more
rapid cartilage degeneration in individuals with OA.
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SERUM LEVELS OF RESISTIN AND INTERLEUKIN-17 ARE ASSOCIATED
WITH INCREASED CARTILAGE DEFECTS AND BONE MARROW
LESIONS IN PATIENTS WITH KNEE SYMPTOMATIC OSTEOARTHRITIS
K. Wang y, J. Xu y, J. Cai y, S. Zheng y, X. Yang y, C. Ding z,y. yDept. of
Rheumatology and Immunology, First Afﬁliated Hosp. of Anhui Med.
Univ., Hefei, China; zMenzies Inst. of Med. Res., Univ. of Tasmania,
Hobart, Australia
Purpose: To investigate cross-sectional associations between serum
levels of resistin and interleukin-17 and cartilage defects and bone
marrow lesions in patients with knee symptomatic osteoarthritis
(OA).
Methods: 194 randomly-selected patients with knee symptomatic OA
(mean 55.4 years, range 34 to 74, 87% females) were included in Anhui
Osteoarthritis (AHOA) Study. Knee cartilage defects and bone marrow
lesions were determined at medial and lateral tibial, femoral and
patellar sites using T2-weighted fat-suppressed fast spin echo MRI.
Serum resistin and IL-17 levels were measured using ELISA.
Results: Serum resistin was positively associated with cartilage defects
at lateral femoral (OR: 1.23, 95%CI 1.12 to 1.35), lateral tibial (OR: 1.14,
95%CI 1.04 to 1.24) and medial tibial (OR: 1.13, 95%CI 1.03 to 1.23) sites
after adjustment for covariates. The signiﬁcant associations were also
present with bone marrow lesions at lateral femoral (OR: 1.19, 95%CI
1.09 to 1.30) and tibial sites (OR: 1.13, 95%CI 1.02 to 1.24) after adjust-
ment for covariates. All these associations remained signiﬁcant after
further adjustment for IL-17. In patients with highest quartiles of hs-CRP
(> 2.45 pg/ml), IL-17 was signiﬁcantly associated with total cartilage
defect score (r¼0.267, p¼0.001) and cartilage defects at nearly all sites
(except for medial tibial) after adjustment for covariates. These sig-
niﬁcant associations decreased in magnitude and became non sig-
niﬁcant at medial femoral, lateral tibial and patellar sites after furtheradjustment for resistin. Similarly, IL-17 was signiﬁcantly associated
with BMLs at lateral and medial femoral sites after adjustment for
covariates, and the association at lateral femoral site became non sig-
niﬁcant after further adjustment for resistin.
Conclusions: Serum levels of resistin are independently and con-
sistently associated with cartilage defects and BMLs in patients with
knee OA. In addition, the associations of serum IL-17 with cartilage
defects and BMLs in patients with a higher inﬂammatory status are
largely mediated by resistin suggesting resistin may play a key role in
cartilage loss and bone abnormalities in patients with knee OA.
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PPARDELTA PROMOTES THE PROGRESSION OF POST-TRAUMATIC
OSTEOARTHRITIS
A. Ratneswaran y, I. Welch y, S.B. Golub z,x, A.J. Fosang z,x, F. Beier y,k.
yDept. of Physiology and Pharmacology, Western Univ., London, ON,
Canada; zDept. of Paediatrics, Univ. of Melbourne, Melbourne, Australia;
xMurdoch Children's Res. Inst., Melbourne, Australia; kChildren's
Hlth.Res. Inst., London, ON, Canada
Purpose: Osteoarthritis is a chronic degenerative joint disorder, char-
acterized by articular cartilage degeneration, subchondral bone thick-
ening, osteophyte formation, and synovial hyperplasia. The human
burden of this disease inﬂuences both the independence and quality of
life of those afﬂicted. Currently there are no pharmacological treat-
ments available to delay or reverse disease progression, and the lack of
available treatments can be attributed due to our incomplete under-
standing of the molecular mechanisms underlying disease initiation
and progression.
Recent ﬁndings from our laboratory indicate that activation of the
nuclear receptor PPARdelta induces the expression of enzymes involved
in proteoglycan breakdown, prompting us to speculate whether
inhibition of PPARdelta could be a viable target for OA treatment.
We aimed to characterize the role of PPARdelta in OA in order to
determinewhether activation of PPARdeltawould correlatewith an OA-
like phenotype and whether the inhibition of this nuclear receptor
could affect OA progression. We hypothesize that inhibition of PPAR-
delta will slow the progression of OA in animal models.
Methods: Primary mouse chondrocytes and cartilage explants were
treated with a pharmacological PPARdelta agonist (GW501516) to
evaluate changes in gene expression (qPCR), aggrecan breakdown (Dye-
binding assay;Western Blotting) and histology (Safranin-O, immuno-
histochemistry) consistent with OA development. Microarrays are
conducted on primary mouse chondrocytes treated with GW501516 to
elucidate information on direct targets of this nuclear receptor. In order
to examine the role of PPARdelta in-vivo, cartilage-speciﬁc knockout
mice and wild-type littermate controls were subjected to destabiliza-
tion of medial meniscus surgery (DMM) at 20 weeks of age. 8 weeks
post-surgery mice were compared through classical histological and
biochemical measures of OA progression including Safranin-O staining
with OARSI scoring, immunohistochemistry for cartilage matrix
breakdown products, and picrosirius red staining for collagen ﬁber
structure and orientation.
Results: In vitro, PPARdelta agonism (by GW501516) results in the
upregulation of expression of proteases implicated in cartilage degen-
eration (including MMPs and ADAMTS genes). Activation of PPARdelta
also results in proteoglycan breakdown in the cartilage matrix in an
explant culture system, as well as increased aggrecan breakdown
products in the medium. Western blots of medium and guanidine
extracts depict speciﬁc aggrecan neoepitopes present in the medium
and guanidine extracts. Microarray results have identiﬁed targets of
PPARdelta, such as those involved in lipid oxidation and transport.
Mice with cartilage-speciﬁc deletion of PPARdelta do not demonstrate
any abnormalities in skeletal growth or development, but show sig-
niﬁcant chondroprotection in comparison to wild-type littermate con-
trols after surgical induction of OA. OARSI scoring and
immunohistochemistry conﬁrm strong protection of mutant mice
against cartilage matrix breakdown, and decreased breakdown prod-
ucts in the cartilage of PPARdelta knockout mice.
Conclusions: This study provides strong evidence for catabolic roles
of endogenous PPARdelta in post-traumatic OA and suggests that
pharmacological inhibition of PPARdelta is a promising therapeutic
strategy.
